Ross J. Kusmick

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Dana-Farber Brigham Cancer Center

Ross J. Kusmick is an author at Dana-Farber Cancer Institute specializing in immunotherapy, her2-positive breast cancer therapy, and her2-positive metastatic disease.

Publications per year

2024–2025

Publications

Abstract PS08-09: Impact of HER2 expression dynamics on the real-world activity of trastuzumab deruxtecan for metastatic breast cancer (RELIEVE)

Paolo Tarantino, Melissa E. Hughes, Ross J. Kusmick et al. · Cancer Research · 2024 · 11 citations

Medicine, Oncology, Pharmacology +17

Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases

Thomas Grinda, Stefania Morganti, Liangge Hsu et al. · npj Breast Cancer · 2025 · 10 citations · Full text

Medicine, Oncology, Pharmacology +16

1–2 of 2